JPMorgan Active Growth ETF offers a high-conviction, actively managed portfolio focused on mega-cap technology and growth ...
Novo Nordisk Tries to Snatch a Weight-Loss Biotech From Pfizer. There Are Political Risks. Denmark’s Novo offers $56.50 a share in cash for Metsera, plus potentially a further $21.25 a share based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback